Penserra Capital Management’s Phibro Animal Health PAHC Stock Holding History

Penserra Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,852	Closed	-$519K	–	1123
2025 Q3	$519K	Buy	+12,852	New	+$424K	0.01%	566
2021 Q4	–	Sell	-465	Closed	-$10K	–	1497
2021 Q3	$10K	Hold	465	–	–	﹤0.01%	1358
2021 Q2	$13K	Buy	465 +5	+1%	+$135	﹤0.01%	1255
2021 Q1	$11K	Sell	460 -5	-1%	-$113	﹤0.01%	1026
2020 Q4	$9K	Buy	+465	New	+$8.55K	﹤0.01%	934
2020 Q2	–	Sell	-680	Closed	-$15K	–	881
2020 Q1	$15K	Hold	680	–	–	﹤0.01%	780
2019 Q4	$16K	Buy	+680	New	+$15.8K	﹤0.01%	803

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Penserra Capital Management's PAHC Position: Q4 2025 in Review

Penserra Capital Management sold out of Phibro Animal Health (PAHC) in Q4 2025, closing a stake of 12,852 shares — an estimated $519K sold.

Penserra Capital Management first reported a position in PAHC in Q4 2019 and held it in 7 quarters. The position peaked at $519K in Q3 2025. 227 funds tracked by Wall St. Rank hold PAHC as of Q4 2025.

Penserra Capital Management reported no remaining Phibro Animal Health position as of Q4 2025 after selling out during the quarter.
Penserra Capital Management sold 12,852 Phibro Animal Health shares in Q4 2025, an estimated $519K.
Penserra Capital Management first reported a position in Phibro Animal Health in Q4 2019 and held it in 7 quarters.
Penserra Capital Management's Phibro Animal Health position peaked at $519K in Q3 2025.
227 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2025.

Based on Penserra Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.